drugset / Trial / NCT00502411

Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma

NCT00502411 ↗

Phase 1 Completed 4 enrolled M.D. Anderson Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to learn if the combination of radiation therapy plus low dose doxorubicin chemotherapy given after surgery is effective in the treatment of sarcoma. The safety of this treatment will also be studied.

Timeline

Start
2003-01
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxorubicin Other / unclassified 17.5 mg/m2 Intravenous

Indications